These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations. Vingopoulou EI, Siarkou VI, Batzias G, Kaltsogianni F, Sianou E, Tzavaras I, Koutinas A, Saridomichelakis MN, Sofianou D, Tzelepi E, Miriagou V. J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836 [Abstract] [Full Text] [Related]
12. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009. Johnson JR, Porter S, Thuras P, Castanheira M. Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533233 [Abstract] [Full Text] [Related]
17. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom. Timofte D, Maciuca IE, Williams NJ, Wattret A, Schmidt V. Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838 [Abstract] [Full Text] [Related]
18. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS. Cristea VC, Oprea M, Neacşu G, Gîlcă R, Popa MI, Usein CR. Roum Arch Microbiol Immunol; 2015 Oct; 74(3-4):73-8. PubMed ID: 27328520 [Abstract] [Full Text] [Related]